Diabetes
Commentary
Hypoglycemia in the elderly: Watch for atypical symptoms
Hypoglycemia in older T2DM patients often presents with atypical neurologic symptoms, including incoordination and ataxia, slurring of speech, and...
From the Journals
Newer antihyperglycemic drugs have distinctive CV, kidney benefits
SGLT2 inhibitors and GLP-1 RAs have different effects on cardiovascular and kidney disease outcomes in patients with type 2 diabetes.
From the Journals
Semaglutide plus SGLT2 inhibitors improves glycemic control in type 2 diabetes
Once-weekly treatment with the GLP-1 RA semaglutide helped most patients with type 2 diabetes on SGLT2 inhibitors meet their glycemic targets and...
Feature
How much difference will Eli Lilly’s half-price insulin make?
Lilly’s move on Humalog could put pressure on the other two big makers of insulin to act.
Case Reports
Sudden-onset rash on the trunk and limbs • morbid obesity • family history of diabetes mellitus • Dx?
► Sudden-onset rash on the trunk and limbs
► Morbid obesity
► Family history of diabetes mellitus
PURLs
Bariatric surgery + medical therapy: Effective Tx for T2DM?
Short-term studies have indicated “Yes,” but does a long-term randomized controlled trial give it a thumbs up?
PURLs
How do these 3 diabetes agents compare in reducing mortality?
A meta-analysis reveals that there may be advantages associated with SGLT-2 inhibitors and GLP-1 agonists that are not associated with DPP-4...
From the Journals
More sleep can help youth manage type 1 diabetes
More sleep can lead to better glycemic control in youth with type 1 diabetes mellitus.
From the Journals
Behavioral intervention improves physical activity in patients with diabetes
Regular sessions with an exercise specialist could yield significant improvements in physical activity in patients with type 2 diabetes.
Conference Coverage
Dermatologists name isobornyl acrylate contact allergen of the year
WASHINGTON – The adhesive ingredient is used in diabetes devices such as insulin pumps.
News
FDA approves label extension for dapagliflozin
The label extension means a broader population with type 2 diabetes and impaired renal function could benefit from treatment with dapagliflozin....